ライフサイエンスコーパス: myotomy

1 ter thoracoscopic and 93% after laparoscopic myotomy).

2 y morbidity has been the major limitation of myotomy.

3 ained time are pneumatic dilation and Heller myotomy.

4 72% (26%) effective vs 84% (20%) for Heller myotomy.

5 option with pneumatic dilatation and Heller myotomy.

6 before and after laparoscopic or endoscopic myotomy.

7 7%), and 4 with type 3 (80%) achalasia after myotomy.

8 e pneumatic dilation and laparoscopic Heller myotomy.

9 studies of both POEM and laparoscopic Heller myotomy.

10 opic therapies before recommending operative myotomy.

11 operative factors associated with successful myotomy.

12 e gastroesophageal reflux (GER) after Heller myotomy.

13 flux procedure should be added to the Heller myotomy.

14 es for continued symptoms of dysphagia after myotomy.

15 num toxin (Botox), and 4 had undergone prior myotomy.

16 x [71%], pneumatic dilation [91%], or Heller myotomy [100%]) than type I (56% overall) or type III (2

17 Thirty-one of 107 patients underwent a myotomy (29%).

18 a fundoplication was added to a laparoscopic myotomy (31.5% without a fundoplication vs. 8.8% with; O

19 Before myotomy, 79% received Botox or bag dilation: 52% had Bot

20 dilation (70%-90% effective) or laparoscopic myotomy (88%-95% effective).

21 Ninety-three percent felt they would undergo myotomy again, if necessary.

22 us Dor Fundoplication was superior to Heller myotomy alone in regard to the incidence of postoperativ

23 emale rabbits were subjected to surgical EAS myotomy and administered local injections of either a Wn

24 culectomy or diverticulopexy with esophageal myotomy and an antireflux procedure.

25 patients have undergone laparoscopic Heller myotomy and been prospectively followed.

26 Studies suggest that surgical myotomy and botulinum toxin injection may provide benefi

27 Laparoscopic Heller myotomy and fundoplication was performed through five up

28 n 60% of tested patients after thoracoscopic myotomy and in 17% after laparoscopic myotomy plus fundo

29 Laparoscopic Heller myotomy and partial fundoplication should be considered

30 reflux disease (GERD) or completing Heller's myotomy and subject today to intense discussions.

31 o assess the long-term outcome of esophageal myotomy and to identify preoperative factors influencing

32 hirty-five patients had a left thoracoscopic myotomy, and 133 patients had a laparoscopic myotomy plu

33 its efficacy compared to pneumatic dilation, myotomy, and combination therapy.

34 September 2011 using the keywords achalasia, myotomy, antireflux surgery, and fundoplication.

35 Both pneumatic dilation and surgical myotomy are effective therapies for achalasia; laparosco

36 Pneumatic dilation and surgical myotomy are the most effective therapeutic options for a

37 Failure of myotomy as defined by persistent or recurrent severe sym

38 r myotomy with the majority (74%) undergoing myotomy as secondary treatment of achalasia.

39 iable prognosis after endoscopic or surgical myotomy based on subtypes, with type II (absent peristal

40 Laparoscopic myotomy can durably relieve symptoms of dysphagia.

41 Laparoscopic Heller myotomy can safely and durably relieve symptoms of dysph

42 At present, pneumatic dilatation and Heller myotomy combined with an anti-reflux procedure are the t

43 to achieve excellent dysphagia relief after myotomy compared with those with LES pressure < or =35 m

44 A 7-cm myotomy extended 6 cm above the GE junction and 1 cm bel

45 lected from patients undergoing laparoscopic myotomy for achalasia at our institution.

46 Among the 209 patients undergoing Heller myotomy for achalasia, 154 received endoscopic therapy b

47 d (1994-2003), 209 patients underwent Heller myotomy for achalasia.

48 t option comparable with laparoscopic Heller myotomy for any of the achalasia syndromes; and 5) post-

49 Heller myotomy had no effect in these patients, but sildenafil

50 ven its low rates of complications, surgical myotomy has become the preferred primary treatment, part

51 Heller myotomy has been shown to be an effective primary treatm

52 Laparoscopic Heller myotomy has been undertaken for over a decade, but most

53 Per-oral endoscopic myotomy has recently been introduced as a new minimally

54 ic myotomy (POEM), an incisionless selective myotomy, has been described as a less invasive surgical

55 tandard for achalasia is laparoscopic Heller myotomy (HM) and partial fundoplication.

56 d 95 laparoscopic and 5 thoracoscopic Heller myotomies in 100 patients (age 49.5 +/- 1.5 years) with

57 nesophageal pressurization disappeared after myotomy in 16 of 19 patients.

58 ric junction relaxation pressure achieved by myotomy in achalasia is associated with partial recovery

59 Myotomy is beneficial in patients with pharyngeal swallo

60 The selection of patients for myotomy is difficult and of major importance to the qual

61 therapies for achalasia; laparoscopic Heller myotomy is emerging as the optimal surgical therapy.

62 Laparoscopic Heller myotomy is strongly encouraged for patients with symptom

63 Laparoscopic myotomy is the preferred treatment of achalasia.

64 Myotomy length was 9 cm (7-12 cm), and the median operat

65 long-term effects after laparoscopic Heller myotomy (LHM) and endoscopic balloon dilation (EBD) cons

66 eumatic dilation (PD) or laparoscopic Heller myotomy (LHM), which have comparable rates of success.

67 ers, verapamil, disopyramide) and the septal myotomy-myectomy operation, which is the standard of car

68 Ventricular septal myotomy/myectomy (Morrow procedure) is the standard surg

69 ology was judged unsuitable for conventional myotomy/myectomy, a novel surgical strategy was designed

70 alternative surgical strategies to standard myotomy/myectomy, similar to those described here.

71 ient to control these symptoms, and surgical myotomy-myomectomy is required.

72 nd nonsurgical septal reduction therapy with myotomy-myomectomy, which is considered to be the standa

73 llent relief of dysphagia after laparoscopic myotomy; none required an esophagectomy.

74 Surgical myotomy of the EAS resulted in significant impairment in

75 Resection of the diverticula and a surgical myotomy of the manometrically defined abnormal segment r

76 ition of infants, is treated by longitudinal myotomy of the pylorus.

77 dysphagia were 0.06 (95% CI, 0.03-0.12) for myotomy only, 0.11 (95% CI, 0.09-0.14) for myotomy with

78 est result were 0.37 (95% CI, 0.12-1.08) for myotomy only, 0.16 (95% CI, 0.11-0.24) for myotomy with

79 es were divided into the following 3 groups: myotomy only, myotomy with anterior fundoplication, and

80 a is most commonly treated with laparoscopic myotomy or endoscopic dilation.

81 need for additionally therapy including redo myotomy or esophagectomy was higher in the endoscopicall

82 th achalasia were assigned to undergo Heller myotomy or Heller myotomy plus Dor fundoplication.

83 After myotomy, patients rarely have abnormal esophageal acid e

84 myotomy, and 133 patients had a laparoscopic myotomy plus a partial fundoplication.

85 Heller Myotomy plus Dor Fundoplication was superior to Heller m

86 assigned to undergo Heller myotomy or Heller myotomy plus Dor fundoplication.

87 Laparoscopic myotomy plus fundoplication corrected reflux present bef

88 scopic myotomy and in 17% after laparoscopic myotomy plus fundoplication.

89 for patients undergoing per-oral endoscopic myotomy (POEM) after our initial 15-case learning curve.

90 to describe a place for per-oral endoscopic myotomy (POEM) among the currently available robust trea

91 Peroral endoscopic myotomy (POEM) and submucosal tunneling and endoscopic r

92 of patients treated with peroral endoscopic myotomy (POEM) in a single European center.

93 Per-oral endoscopic myotomy (POEM) is a less invasive flexible endoscopic al

94 udies have indicated that peroral endoscopic myotomy (POEM) might be a safe and effective treatment f

95 Per-oral endoscopic myotomy (POEM), an incisionless selective myotomy, has b

96 or full eye closure after OO paralysis or RB myotomy, respectively.

97 Following myotomy, the EAS muscle was replaced with fibrous tissue

98 After myotomy, the frequency and severity of symptoms of achal

99 ns reviewed included EBTI, EBD, and surgical myotomy using open and minimally invasive techniques.

100 phagia score was 7.1 +/- 2.6; therefore, the myotomy was considered successful when the delta score w

101 The length of the myotomy was determined by the extent of the motility abn

102 Laparoscopic myotomy was performed by incising the distal 4 to 6 cm o

103 Laparoscopic myotomy, when combined with an antireflux procedure, pro

104 toperative dysphagia in the group undergoing myotomy with anterior fundoplication compared with the g

105 r myotomy only, 0.11 (95% CI, 0.09-0.14) for myotomy with anterior fundoplication, and 0.06 (95% CI,

106 r myotomy only, 0.16 (95% CI, 0.11-0.24) for myotomy with anterior fundoplication, and 0.18 (95% CI,

107 d into the following 3 groups: myotomy only, myotomy with anterior fundoplication, and myotomy with p

108 Laparoscopic myotomy with fundoplication was the most effective surgi

109 oscopic balloon dilation (EBD), and surgical myotomy with or without a fundoplication; however, repor

110 plication compared with the group undergoing myotomy with posterior fundoplication were statistically

111 oplication, and 0.18 (95% CI, 0.13-0.25) for myotomy with posterior fundoplication.

112 oplication, and 0.06 (95% CI, 0.04-0.08) for myotomy with posterior fundoplication.

113 y, myotomy with anterior fundoplication, and myotomy with posterior fundoplication.

114 t outcomes in 209 patients undergoing Heller myotomy with the majority (74%) undergoing myotomy as se

115 sia, which combines the efficacy of surgical myotomy, with the benefits of an endoscopic procedure.